Metraipolis › archive › dc_fee5251f1085
Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42496442
- DOI
- 10.3390/hematolrep18040043
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T06:21:52.437Z
- SHA-256 of the archived text
f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca- Stable URL of this page
https://metraipolis.com/documento/dc_fee5251f1085
How to cite
Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442 — Europe PMC (en), https://europepmc.org/article/MED/42496442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fee5251f1085 (Metraipolis archive dc_fee5251f1085, sha256 f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca)
BibTeX
@misc{dcfee5251f1085,
title = {Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42496442},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fee5251f1085; sha256 f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42496442. Agents can read the archived copy with the MCP tool read_document.